Amgen

Open: 261.54 Close: 262.06 Change: 0.52

You don't have read the whole internet to decide whether to invest in Amgen Company Inc. Use an AI.

How much time have you spent trying to decide whether investing in Amgen? Many investors start with the dream of being free. They expect to find on the stock market an option to have time to develop their own interests and hobbies. That is, a way to escape a 9 to 5 job. However, investment is complex and investors end up spending whole days (and nights) trying to figure out which the right stock to invest is. The dream of stock investing becomes the nightmare of facing infinity amounts of information. As a solution, we programmed an artificial intelligence that reads the whole internet and the uses natural language processing and vectorizers to summarize the information. Usually, the AI reads several hundred pages and summarize it to a short document. This document presents our results. We found that the most common words in the internet about Amgen are: Amgen, stock, …

Concept Map

Semantic Network

Stock Summary

Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide. The company's products include Enbrel, Prolia, Xgeva, Otezla, Aranesp, and Repatha..

Today's Summary

Amgen declares $2.13 dividend. Amgen expects full-year earnings in the range of $17.80 to $18.80 per share.

Today's News

Amgen manufactures the breast cancer drug Enbrel, priced at over $82,000 per year and costs the average Medicare enrollee over $2,450 per year out-of-pocket. Amgen opposed the Biden administration reforms that lower prescription drug prices. Amgen is looking to Q2 top, bottom line beats after missing in Q1. Amgen declares $2.13 dividend. The main benchmarks closed higher ahead of this weeks key inflation update. Blue chip stocks for drugmaker Amgen ( AMGN ) and aircraft manufacturer Boeing (BAK) put in an impressive post-earnings showing up boosting the 30-stock index. Amgen Inc.s ( AMGN ) dividend yield is 3.29%, which means that for every $100 invested in the company, investors would receive $3.29 in dividends per year. Amgens payout ratio is 54.57% which means. that 54% of the companys earnings are paid out as dividends. Amgen : 262.06 (+1.06%) Amgen: Q2 Earnings Snapshot AP - Thu Aug 3, 3:36PM CDT Amgen announces financial results for the second quarter of 2023. Amgen is advancing the largest early Oncology pipeline in our history spanning several innovative technology platforms - Bispecific T Cell Engagers (BiTE s), Bispecular Antibodies, Small Molecules - across many targets and more than a dozen tumor types. Amgen expects full-year earnings in the range of $17.80 to $18.80 per share. Amgen shares have dropped 12% since the beginning of the year, while the S&Ps 500 index has climbed. Sales of Amjevita, Amgens biosimilar version of AbbVies (ABBV.N) arthritis drug Humira, totaled $150 million, short of Wall Street expectations. Amgen stock (NASDAQ:AMGN), quotes and news summary - benzinga.com. amgen stock price, news, charts, charts and stock research, profile. Amgen (NASDAQ:AMGN) is in the Health Care sector and Biotechnology industry. There is no upcoming split for Amgen. Amgen (NASDAQ:AMGN) is in the Health Care sector and Biotechnology industry. Amgens Q3 earnings are confirmed for Thursday, November 2, 2023. The stock price for Amgen is $ 262.06 last updated today at 8:00 PM UTC UTC. Amgen Inc. (AMGN) Up 5.74% To $243.94 after Earnings Beat on Friday, August 4. Amgen (AMGN) stock price, news, charts, charts and stock research, profile. Amgen is in the Health Care sector and Biotechnology industry. There is no upcoming split. Amgen (NASDAQ:AMGN) is in the Health Care sector and Biotechnology industry. Q3 earnings are confirmed for November 2, 2023. Amgen (NASDAQ:AMGN) is in the Health Care sector and Biotechnology industry. Amgens Q3 earnings are confirmed for Thursday, November 2, 2023. There is no upcoming split for Amgen. Amgen Inc. (AMGN) Up 5.74% To $243.94 After Earnings Beat InvestorsObserver - 6 days ago. Amgen (AMGN) stock price, news, charts, charts and stock research, profile. Amgen is in the Health Care sector and Biotechnology industry. There is no upcoming split. Amgen (NASDAQ:AMGN) is in the Health Care sector and Biotechnology industry. There is no upcoming split for Amgen. Amgen (NASDAQ:AMGN) is in the Health Care sector and Biotechnology industry. There is no upcoming split for Amgen. Q3 earnings are confirmed for Thursday, November 2, 2023. Amgen Inc. (AMGN) Up 5.74% To $243.94 After Earnings Beat on Friday, August 4. There is no upcoming split for Amgen. Q Is Amgen (AMGN) going to split? A Amgen is in the Health Care sector and Biotechnology industry.

Stock Profile

"Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide. It focuses on inflammation, oncology/hematology, bone health, cardiovascular disease, nephrology, and neuroscience areas. The company's products include Enbrel to treat plaque psoriasis, rheumatoid arthritis, and psoriatic arthritis; Neulasta that reduces the chance of infection due a low white blood cell count in patients cancer; Prolia to treat postmenopausal women with osteoporosis; Xgeva for skeletal-related events prevention; Otezla for the treatment of adult patients with plaque psoriasis, psoriatic arthritis, and oral ulcers associated with Behçet's disease; Aranesp to treat a lower-than-normal number of red blood cells and anemia; KYPROLIS to treat patients with relapsed or refractory multiple myeloma; and Repatha, which reduces the risks of myocardial infarction, stroke, and coronary revascularization. It also markets Nplate, Vectibix, MVASI, Parsabiv, EPOGEN, KANJINTI, BLINCYTO, Aimovig, EVENITY, AMGEVITATM, Sensipar/Mimpara, NEUPOGEN, IMLYGIC, Corlanor, and AVSOLA. Amgen Inc. serves healthcare providers, including physicians or their clinics, dialysis centers, hospitals, and pharmacies. It distributes its products through pharmaceutical wholesale distributors, as well as direct-to-consumer channels. It has collaboration agreements with Novartis Pharma AG; UCB; Bayer HealthCare LLC; BeiGene, Ltd.; Eli Lilly and Company; Datos Health; and Verastem, Inc. to evaluate VS-6766 in combination with lumakrastm (Sotorasib) in patients with KRAS G12C-mutant non-small cell lung cancer. It has an agreement with Kyowa Kirin Co., Ltd. to jointly develop and commercialize KHK4083, a Phase 3-ready anti-OX40 fully human monoclonal antibody for the treatment of atopic dermatitis and other autoimmune diseases; and research and development collaboration with Neumora Therapeutics, Inc. and Plexium, Inc. Amgen Inc. was incorporated in 1980 and is headquartered in Thousand Oaks, California."

Keywords

The game is changing. There is a new strategy to evaluate Amgen fundamental value, possible risks and most salient advantages. Investors have traditionally relied in reading large amounts of text to evaluate the fundamental value of a stock or company. However, the development of Artificial Intelligence (AI) tools is modifying the way investments are evaluated in markets. Today, machine learning, natural language processing and bigdata allow making this process automatic, reducing large amounts of text to the elements that have a higher activation in a neural network. We programmed an artificial intelligence that reads the whole internet and the uses natural language processing and vectorizers to summarize the information. Usually, the AI reads several hundred pages and summarize it to a short document. This document presents our results. We found that the most common words in the internet about Amgen are: Amgen, stock, Health, Care, sector, Biotechnology, industry, and the most common words in the summary are: amgen, job, stock, inc, market, best, amgn, . One of the sentences in the summary was: Amgen declares $2.13 dividend. Other searches related to this term that the AI found were: stockmarketlive, livestock, stockmarketforbeginners, thestockmarket, stockmarkettoday, stockmarkettrading, stockmarketstocks, todaystockmarket, thestockmarket, marketnews, stockmarketnews, whatisstockmarket, usstockmarket, stockmarketopen. #amgen #job #stock #inc #market #best #amgn.